請更新您的瀏覽器

您使用的瀏覽器版本較舊,已不再受支援。建議您更新瀏覽器版本,以獲得最佳使用體驗。

Auto Shanghai 2025: Nullmax to Showcase MaxDrive - From Active Safety to End-to-End Autonomous Driving

PR Newswire (美通社)

更新於 2025年04月14日09:59 • 發布於 2025年04月14日09:01 • PR Newswire

SHANGHAI, April 14, 2025 /PRNewswire/ -- Nullmax, an artificial intelligence company specializing in autonomous driving applications, announced its debut at the 2025 Shanghai International Automobile Industry Exhibition (April 23-May 2). At Booth 8BA005 in Hall 8.2 of the National Exhibition and Convention Center (Shanghai), the company will showcase its full-range autonomous driving solutions and end-to-end technologies while hosting industry leaders for technical exchange and business networking opportunities.

Auto Shanghai 2025 Invitation

Auto Shanghai 2025 Invitation

As a key player in the industry, Nullmax is committed to advancing the mass adoption of autonomous driving through cutting-edge AI technology. At this year's Auto Show, the company will highlight its MaxDrive Automated Driving Solution, which covers full-scenario functionalities—from basic ADAS to high-level urban NOA—catering to diverse vehicle models and market demands.

Leveraging its platform-based technical architecture, Nullmax's solution can be flexibly and rapidly adapted to mainstream autonomous driving chips and varying sensor configurations worldwide, empowering automakers to efficiently achieve differentiated mass production.

Nullmax cordially invites industry partners, media, and visitors to visit Booth 8BA005 in Hall 8.2 to explore the latest advancements in autonomous driving technology and potential collaboration opportunities.

About Nullmax

Nullmax, an AI technology company founded in Silicon Valley in 2016 with an R&D center in Shanghai, specializes in AD/ADAS solutions for all scenarios, driving the intelligent transformation of transportation.

查看原始文章

Trip.com Unveils 2025 Trip.Best Global Rankings: New Destinations, Themes & Trends

PR Newswire (美通社)

CNOOC Brings On-stream Wenchang 9-7 Oilfield Development Project

PR Newswire (美通社)

PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets

PR Newswire (美通社)
查看更多
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...